A. Lopes et al., PROGNOSTIC FACTORS IN CARCINOMA OF THE PENIS - MULTIVARIATE-ANALYSIS OF 145 PATIENTS TREATED WITH AMPUTATION AND LYMPHADENECTOMY, The Journal of urology, 156(5), 1996, pp. 1637-1642
Purpose: The major issue in penile cancer is deciding who should or sh
ould not undergo lymph node dissection. Clinical and invasive methods
are not reliable for staging. Clinical and pathological factors involv
ed in lymph node metastases and prognosis were evaluated in 145 patien
ts with penile carcinoma staged according to the 1978 TNM system, and
treated with amputation and lymphadenectomy. Materials and Methods: Cl
inical factors studied were patient age, race, disease evolution time,
symptoms, and clinical T and N stages. Pathological factors of the pr
imary tumor considered were tumor thickness, histological grade, lymph
atic and venous embolization, infiltration of the corpora cavernosa, c
orpus spongiosum and urethra, mononuclear and eosinophilic infiltrates
, and cell alterations suggestive of human papillomavirus. All slides
were reviewed by 1 pathologist. The Cox regression hazards method for
multifactorial analysis was used. Results: Followup ranged from 0.7 to
453.2 months (mean 85.8, median 32.7). The 5-year disease-free and ov
erall survival rates were 45.3 and 54.3%, respectively. Venous and lym
phatic embolizations were the main factors affecting significantly the
incidence of lymph node metastasis, which were the main risks factors
for recurrence and death. Pathologically proved infiltration of the c
orpora cavernosa, urethra and adjacent structures, which corresponded
to stages T2, T3 and T4 disease, respectively, of the current TNM clas
sification, were not significant predictors for incidence of lymph nod
e metastasis, disease-free and overall survival or risk factors for re
currence and death. Conclusions: Because venous and lymphatic emboliza
tions were related to greatest risk of lymph node metastasis, we propo
se their evaluation in staging and therapeutic planning of patients wi
th infiltrative tumors of the penis.